MRK vs CAH
By Alex · Tickerpine
Merck & Co., Inc. vs Cardinal Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | CAH |
|---|---|---|
| Price | $156.45 | $237.92 |
| Market cap | $385.99B | $55.33B |
| P/E ratio | 120.3 | 32.9 |
| ROE | 6.96% | — |
| Profit margin | 4.77% | 0.67% |
| Revenue growth | 5.10% | 5.80% |
| Dividend yield | 2.26% | 0.89% |
| Beta | 0.21 | 0.52 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs CAH in plain English
- MRK is the bigger company — about 7.0× the market cap of CAH.
- CAH is cheaper on earnings (P/E 32.9 vs 120.3).
- CAH is growing revenue faster (6% vs 5%).
- MRK has the higher dividend yield (2.26% vs 0.89%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
CAH return calculator
See what $1,000 in Cardinal Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.